Effect of the Melanocortin 4-Receptor Ile269Asn Mutation on Weight Loss Response to Dietary, Phentermine and Bariatric Surgery Interventions

The loss of function melanocortin 4-receptor (<i>MC4R</i>) Ile269Asn mutation has been proposed as one of the most important genetic contributors to obesity in the Mexican population. However, whether patients bearing this mutation respond differently to weight loss treatments is unknown...

Full description

Bibliographic Details
Main Authors: Itzel G. Salazar-Valencia, Hugo Villamil-Ramírez, Francisco Barajas-Olmos, Martha Guevara-Cruz, Luis R. Macias-Kauffer, Humberto García-Ortiz, Omar Hernández-Vergara, David Alberto Díaz de Sandy-Galán, Paola León-Mimila, Federico Centeno-Cruz, Luis E. González-Salazar, Rocío Guizar-Heredia, Edgar Pichardo-Ontiveros, Leonor Jacobo-Albavera, Rosalinda Posadas-Sánchez, Gilberto Vargas-Alarcón, Rafael Velazquez-Cruz, Ruth Gutiérrez-Aguilar, Carlos Zerrweck, Héctor Isaac Rocha-González, Juan Gerardo Reyes-García, Miriam del C. Carrasco-Portugal, Francisco Javier Flores-Murrieta, Armando R. Tovar, Lorena Orozco, Teresa Villarreal-Molina, Samuel Canizales-Quinteros
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Genes
Subjects:
Online Access:https://www.mdpi.com/2073-4425/13/12/2267
_version_ 1797457915086372864
author Itzel G. Salazar-Valencia
Hugo Villamil-Ramírez
Francisco Barajas-Olmos
Martha Guevara-Cruz
Luis R. Macias-Kauffer
Humberto García-Ortiz
Omar Hernández-Vergara
David Alberto Díaz de Sandy-Galán
Paola León-Mimila
Federico Centeno-Cruz
Luis E. González-Salazar
Rocío Guizar-Heredia
Edgar Pichardo-Ontiveros
Leonor Jacobo-Albavera
Rosalinda Posadas-Sánchez
Gilberto Vargas-Alarcón
Rafael Velazquez-Cruz
Ruth Gutiérrez-Aguilar
Carlos Zerrweck
Héctor Isaac Rocha-González
Juan Gerardo Reyes-García
Miriam del C. Carrasco-Portugal
Francisco Javier Flores-Murrieta
Armando R. Tovar
Lorena Orozco
Teresa Villarreal-Molina
Samuel Canizales-Quinteros
author_facet Itzel G. Salazar-Valencia
Hugo Villamil-Ramírez
Francisco Barajas-Olmos
Martha Guevara-Cruz
Luis R. Macias-Kauffer
Humberto García-Ortiz
Omar Hernández-Vergara
David Alberto Díaz de Sandy-Galán
Paola León-Mimila
Federico Centeno-Cruz
Luis E. González-Salazar
Rocío Guizar-Heredia
Edgar Pichardo-Ontiveros
Leonor Jacobo-Albavera
Rosalinda Posadas-Sánchez
Gilberto Vargas-Alarcón
Rafael Velazquez-Cruz
Ruth Gutiérrez-Aguilar
Carlos Zerrweck
Héctor Isaac Rocha-González
Juan Gerardo Reyes-García
Miriam del C. Carrasco-Portugal
Francisco Javier Flores-Murrieta
Armando R. Tovar
Lorena Orozco
Teresa Villarreal-Molina
Samuel Canizales-Quinteros
author_sort Itzel G. Salazar-Valencia
collection DOAJ
description The loss of function melanocortin 4-receptor (<i>MC4R</i>) Ile269Asn mutation has been proposed as one of the most important genetic contributors to obesity in the Mexican population. However, whether patients bearing this mutation respond differently to weight loss treatments is unknown. We tested the association of this mutation with obesity in 1683 Mexican adults, and compared the response of mutation carriers and non-carriers to three different weight loss interventions: dietary restriction intervention, phentermine 30 mg/day treatment, and Roux-en-Y gastric bypass (RYGB) surgery. The Ile269Asn mutation was associated with obesity [OR = 3.8, 95% CI (1.5–9.7), <i>p</i> = 0.005]. Regarding interventions, in the dietary restriction group only two patients were <i>MC4R</i> Ile269Asn mutation carriers. After 1 month of treatment, both mutation carriers lost weight: −4.0 kg (−2.9%) in patient 1, and −1.8 kg (−1.5%) in patient 2; similar to the mean weight loss observed in six non-carrier subjects (−2.9 kg; −2.8%). Phentermine treatment produced similar weight loss in six carriers (−12.7 kg; 15.5%) and 18 non-carriers (−11.3 kg; 13.6%) after 6 months of pharmacological treatment. RYGB also caused similar weight loss in seven carriers (29.9%) and 24 non-carriers (27.8%), 6 months after surgery. Our findings suggest that while the presence of a single <i>MC4R</i> loss of function Ile269Asn allele significantly increases obesity risk, the presence of at least one functional <i>MC4R</i> allele seems sufficient to allow short-term weight loss in response to dietary restriction, phentermine and RYGB. Thus, these three different interventions may be useful for the short-term treatment of obesity in <i>MC4R</i> Ile269Asn mutation carriers.
first_indexed 2024-03-09T16:29:37Z
format Article
id doaj.art-9808d9e3722348d58bcd768de68b77f1
institution Directory Open Access Journal
issn 2073-4425
language English
last_indexed 2024-03-09T16:29:37Z
publishDate 2022-12-01
publisher MDPI AG
record_format Article
series Genes
spelling doaj.art-9808d9e3722348d58bcd768de68b77f12023-11-24T15:03:55ZengMDPI AGGenes2073-44252022-12-011312226710.3390/genes13122267Effect of the Melanocortin 4-Receptor Ile269Asn Mutation on Weight Loss Response to Dietary, Phentermine and Bariatric Surgery InterventionsItzel G. Salazar-Valencia0Hugo Villamil-Ramírez1Francisco Barajas-Olmos2Martha Guevara-Cruz3Luis R. Macias-Kauffer4Humberto García-Ortiz5Omar Hernández-Vergara6David Alberto Díaz de Sandy-Galán7Paola León-Mimila8Federico Centeno-Cruz9Luis E. González-Salazar10Rocío Guizar-Heredia11Edgar Pichardo-Ontiveros12Leonor Jacobo-Albavera13Rosalinda Posadas-Sánchez14Gilberto Vargas-Alarcón15Rafael Velazquez-Cruz16Ruth Gutiérrez-Aguilar17Carlos Zerrweck18Héctor Isaac Rocha-González19Juan Gerardo Reyes-García20Miriam del C. Carrasco-Portugal21Francisco Javier Flores-Murrieta22Armando R. Tovar23Lorena Orozco24Teresa Villarreal-Molina25Samuel Canizales-Quinteros26Unidad de Genómica de Poblaciones Aplicada a la Salud, Facultad de Química, Universidad Nacional Autónoma de México (UNAM), Mexico City 14610, MexicoUnidad de Genómica de Poblaciones Aplicada a la Salud, Facultad de Química, Universidad Nacional Autónoma de México (UNAM), Mexico City 14610, MexicoLaboratorio de Immunogenómica y Enfermedades Metabólicas, Instituto Nacional de Medicina Genómica (INMEGEN), Mexico City 14610, MexicoDepartmento de Fisiología de la Nutrición, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City 14080, MexicoUnidad de Genómica de Poblaciones Aplicada a la Salud, Facultad de Química, Universidad Nacional Autónoma de México (UNAM), Mexico City 14610, MexicoLaboratorio de Immunogenómica y Enfermedades Metabólicas, Instituto Nacional de Medicina Genómica (INMEGEN), Mexico City 14610, MexicoUnidad de Genómica de Poblaciones Aplicada a la Salud, Facultad de Química, Universidad Nacional Autónoma de México (UNAM), Mexico City 14610, MexicoUnidad de Genómica de Poblaciones Aplicada a la Salud, Facultad de Química, Universidad Nacional Autónoma de México (UNAM), Mexico City 14610, MexicoUnidad de Genómica de Poblaciones Aplicada a la Salud, Facultad de Química, Universidad Nacional Autónoma de México (UNAM), Mexico City 14610, MexicoLaboratorio de Immunogenómica y Enfermedades Metabólicas, Instituto Nacional de Medicina Genómica (INMEGEN), Mexico City 14610, MexicoDepartmento de Fisiología de la Nutrición, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City 14080, MexicoDepartmento de Fisiología de la Nutrición, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City 14080, MexicoDepartmento de Fisiología de la Nutrición, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City 14080, MexicoLaboratorio de Genómica de Enfermedades Cardiovasculares, Instituto Nacional de Medicina Genómica (INMEGEN), Mexico City 14610, MexicoDepartamento de Endocrinología, Instituto Nacional de Cardiología Ignacio Chávez (INCICh), Mexico City 14080, MexicoDepartamento de Biología Molecular, Instituto Nacional de Cardiología Ignacio Chávez (INCICh), Mexico City 14080, MexicoLaboratorio de Genómica del Metabolismo Óseo, Instituto Nacional de Medicina Genómica (INMEGEN), Mexico City 14610, MexicoLaboratorio de Enfermedades Metabólicas: Obesidad y Diabetes, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Hospital Infantil de México “Federico Gómez”, Mexico City 06720, MexicoClínica de Obesidad del Hospital General Tláhuac, Mexico City 13250, MexicoSección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City 11340, MexicoSección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City 11340, MexicoUnidad de Investigación en Farmacología, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, MexicoSección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City 11340, MexicoDepartmento de Fisiología de la Nutrición, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City 14080, MexicoLaboratorio de Immunogenómica y Enfermedades Metabólicas, Instituto Nacional de Medicina Genómica (INMEGEN), Mexico City 14610, MexicoLaboratorio de Genómica de Enfermedades Cardiovasculares, Instituto Nacional de Medicina Genómica (INMEGEN), Mexico City 14610, MexicoUnidad de Genómica de Poblaciones Aplicada a la Salud, Facultad de Química, Universidad Nacional Autónoma de México (UNAM), Mexico City 14610, MexicoThe loss of function melanocortin 4-receptor (<i>MC4R</i>) Ile269Asn mutation has been proposed as one of the most important genetic contributors to obesity in the Mexican population. However, whether patients bearing this mutation respond differently to weight loss treatments is unknown. We tested the association of this mutation with obesity in 1683 Mexican adults, and compared the response of mutation carriers and non-carriers to three different weight loss interventions: dietary restriction intervention, phentermine 30 mg/day treatment, and Roux-en-Y gastric bypass (RYGB) surgery. The Ile269Asn mutation was associated with obesity [OR = 3.8, 95% CI (1.5–9.7), <i>p</i> = 0.005]. Regarding interventions, in the dietary restriction group only two patients were <i>MC4R</i> Ile269Asn mutation carriers. After 1 month of treatment, both mutation carriers lost weight: −4.0 kg (−2.9%) in patient 1, and −1.8 kg (−1.5%) in patient 2; similar to the mean weight loss observed in six non-carrier subjects (−2.9 kg; −2.8%). Phentermine treatment produced similar weight loss in six carriers (−12.7 kg; 15.5%) and 18 non-carriers (−11.3 kg; 13.6%) after 6 months of pharmacological treatment. RYGB also caused similar weight loss in seven carriers (29.9%) and 24 non-carriers (27.8%), 6 months after surgery. Our findings suggest that while the presence of a single <i>MC4R</i> loss of function Ile269Asn allele significantly increases obesity risk, the presence of at least one functional <i>MC4R</i> allele seems sufficient to allow short-term weight loss in response to dietary restriction, phentermine and RYGB. Thus, these three different interventions may be useful for the short-term treatment of obesity in <i>MC4R</i> Ile269Asn mutation carriers.https://www.mdpi.com/2073-4425/13/12/2267melanocortin-4-receptorIle269Asn-mutationobesityweight-lossinterventions
spellingShingle Itzel G. Salazar-Valencia
Hugo Villamil-Ramírez
Francisco Barajas-Olmos
Martha Guevara-Cruz
Luis R. Macias-Kauffer
Humberto García-Ortiz
Omar Hernández-Vergara
David Alberto Díaz de Sandy-Galán
Paola León-Mimila
Federico Centeno-Cruz
Luis E. González-Salazar
Rocío Guizar-Heredia
Edgar Pichardo-Ontiveros
Leonor Jacobo-Albavera
Rosalinda Posadas-Sánchez
Gilberto Vargas-Alarcón
Rafael Velazquez-Cruz
Ruth Gutiérrez-Aguilar
Carlos Zerrweck
Héctor Isaac Rocha-González
Juan Gerardo Reyes-García
Miriam del C. Carrasco-Portugal
Francisco Javier Flores-Murrieta
Armando R. Tovar
Lorena Orozco
Teresa Villarreal-Molina
Samuel Canizales-Quinteros
Effect of the Melanocortin 4-Receptor Ile269Asn Mutation on Weight Loss Response to Dietary, Phentermine and Bariatric Surgery Interventions
Genes
melanocortin-4-receptor
Ile269Asn-mutation
obesity
weight-loss
interventions
title Effect of the Melanocortin 4-Receptor Ile269Asn Mutation on Weight Loss Response to Dietary, Phentermine and Bariatric Surgery Interventions
title_full Effect of the Melanocortin 4-Receptor Ile269Asn Mutation on Weight Loss Response to Dietary, Phentermine and Bariatric Surgery Interventions
title_fullStr Effect of the Melanocortin 4-Receptor Ile269Asn Mutation on Weight Loss Response to Dietary, Phentermine and Bariatric Surgery Interventions
title_full_unstemmed Effect of the Melanocortin 4-Receptor Ile269Asn Mutation on Weight Loss Response to Dietary, Phentermine and Bariatric Surgery Interventions
title_short Effect of the Melanocortin 4-Receptor Ile269Asn Mutation on Weight Loss Response to Dietary, Phentermine and Bariatric Surgery Interventions
title_sort effect of the melanocortin 4 receptor ile269asn mutation on weight loss response to dietary phentermine and bariatric surgery interventions
topic melanocortin-4-receptor
Ile269Asn-mutation
obesity
weight-loss
interventions
url https://www.mdpi.com/2073-4425/13/12/2267
work_keys_str_mv AT itzelgsalazarvalencia effectofthemelanocortin4receptorile269asnmutationonweightlossresponsetodietaryphentermineandbariatricsurgeryinterventions
AT hugovillamilramirez effectofthemelanocortin4receptorile269asnmutationonweightlossresponsetodietaryphentermineandbariatricsurgeryinterventions
AT franciscobarajasolmos effectofthemelanocortin4receptorile269asnmutationonweightlossresponsetodietaryphentermineandbariatricsurgeryinterventions
AT marthaguevaracruz effectofthemelanocortin4receptorile269asnmutationonweightlossresponsetodietaryphentermineandbariatricsurgeryinterventions
AT luisrmaciaskauffer effectofthemelanocortin4receptorile269asnmutationonweightlossresponsetodietaryphentermineandbariatricsurgeryinterventions
AT humbertogarciaortiz effectofthemelanocortin4receptorile269asnmutationonweightlossresponsetodietaryphentermineandbariatricsurgeryinterventions
AT omarhernandezvergara effectofthemelanocortin4receptorile269asnmutationonweightlossresponsetodietaryphentermineandbariatricsurgeryinterventions
AT davidalbertodiazdesandygalan effectofthemelanocortin4receptorile269asnmutationonweightlossresponsetodietaryphentermineandbariatricsurgeryinterventions
AT paolaleonmimila effectofthemelanocortin4receptorile269asnmutationonweightlossresponsetodietaryphentermineandbariatricsurgeryinterventions
AT federicocentenocruz effectofthemelanocortin4receptorile269asnmutationonweightlossresponsetodietaryphentermineandbariatricsurgeryinterventions
AT luisegonzalezsalazar effectofthemelanocortin4receptorile269asnmutationonweightlossresponsetodietaryphentermineandbariatricsurgeryinterventions
AT rocioguizarheredia effectofthemelanocortin4receptorile269asnmutationonweightlossresponsetodietaryphentermineandbariatricsurgeryinterventions
AT edgarpichardoontiveros effectofthemelanocortin4receptorile269asnmutationonweightlossresponsetodietaryphentermineandbariatricsurgeryinterventions
AT leonorjacoboalbavera effectofthemelanocortin4receptorile269asnmutationonweightlossresponsetodietaryphentermineandbariatricsurgeryinterventions
AT rosalindaposadassanchez effectofthemelanocortin4receptorile269asnmutationonweightlossresponsetodietaryphentermineandbariatricsurgeryinterventions
AT gilbertovargasalarcon effectofthemelanocortin4receptorile269asnmutationonweightlossresponsetodietaryphentermineandbariatricsurgeryinterventions
AT rafaelvelazquezcruz effectofthemelanocortin4receptorile269asnmutationonweightlossresponsetodietaryphentermineandbariatricsurgeryinterventions
AT ruthgutierrezaguilar effectofthemelanocortin4receptorile269asnmutationonweightlossresponsetodietaryphentermineandbariatricsurgeryinterventions
AT carloszerrweck effectofthemelanocortin4receptorile269asnmutationonweightlossresponsetodietaryphentermineandbariatricsurgeryinterventions
AT hectorisaacrochagonzalez effectofthemelanocortin4receptorile269asnmutationonweightlossresponsetodietaryphentermineandbariatricsurgeryinterventions
AT juangerardoreyesgarcia effectofthemelanocortin4receptorile269asnmutationonweightlossresponsetodietaryphentermineandbariatricsurgeryinterventions
AT miriamdelccarrascoportugal effectofthemelanocortin4receptorile269asnmutationonweightlossresponsetodietaryphentermineandbariatricsurgeryinterventions
AT franciscojavierfloresmurrieta effectofthemelanocortin4receptorile269asnmutationonweightlossresponsetodietaryphentermineandbariatricsurgeryinterventions
AT armandortovar effectofthemelanocortin4receptorile269asnmutationonweightlossresponsetodietaryphentermineandbariatricsurgeryinterventions
AT lorenaorozco effectofthemelanocortin4receptorile269asnmutationonweightlossresponsetodietaryphentermineandbariatricsurgeryinterventions
AT teresavillarrealmolina effectofthemelanocortin4receptorile269asnmutationonweightlossresponsetodietaryphentermineandbariatricsurgeryinterventions
AT samuelcanizalesquinteros effectofthemelanocortin4receptorile269asnmutationonweightlossresponsetodietaryphentermineandbariatricsurgeryinterventions